Home / Adalimumab / Italy
IT ATC L04AB04 · updated 2 Nov 2026
Adalimumab shortage in Italy
Is there an Adalimumab shortage in Italy?
Yes. As of 2 Nov 2026, 4 Adalimumab products are reported short in Italy, the first since 6 Aug 2026. No return date has been given. Main reason: increased demand.
Also short in United States, Germany, Spain, Austria, Belgium, Czechia, Sweden. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | HYRIMOZ | SANDOZ GMBH | 6 Aug 2026 | not given | Increased demand Elevata richiesta/problemi produttivi |
| IT | IDACIO | FRESENIUS KABI DEUTSCHLAND GMBH | 1 Sep 2026 | not given | Increased demand Elevata richiesta |
| IT | HYRIMOZ | SANDOZ GMBH | 19 Oct 2026 | not given | Increased demand Elevata richiesta |
| IT | IDACIO anticipated | FRESENIUS KABI DEUTSCHLAND GMBH | 7 Nov 2026 | not given | Manufacturing problem Problemi produttivi: distribuzione contingentata |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.